MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Mutual FundPosition in AKTS — Aktis Oncology, Inc.
CIK 1705339
CAUSEWAY BAY, K3
Position in AKTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$172,656
New position
Shares Held
9,651
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,178,526 across 240 Biotechnology names. AKTS ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
171,925 | $76,771,388 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,854 | $53,971,993 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
81,325 | $26,908,001 | |
| 4 | INSM |
INSMED Inc
|
122,958 | $20,106,091 | |
| 5 | RPRX |
Royalty Pharma plc
|
419,129 | $20,105,617 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
27,744 | $8,938,838 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
139,598 | $8,752,793 | |
| 8 | MRNA |
Moderna, Inc.
|
147,589 | $7,497,520 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,656 | 9,651 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||